Equities researchers at Jefferies Financial Group assumed coverage on shares of Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) in a report released on Tuesday, Marketbeat.com reports. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback